Celularity Announces Full Year 2024 Operating and Financial Results

Net revenues for the year ending December 31, 2024, totaled $54.2 million, an increase of$31.4 million, or 138.1%, compared to the previous year.FLORHAM PARK, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced operating and financial results for the year ended December 31, 2024. “We built momentum through 2024 and ended the year with a strong finish, as reflected in higher net revenues from the ...